BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27733450)

  • 1. New function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration.
    Pasteuning-Vuhman S; Boertje-van der Meulen JW; van Putten M; Overzier M; Ten Dijke P; Kiełbasa SM; Arindrarto W; Wolterbeek R; Lezhnina KV; Ozerov IV; Aliper AM; Hoogaars WM; Aartsma-Rus A; Loomans CJ
    FASEB J; 2017 Jan; 31(1):238-255. PubMed ID: 27733450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-type specific regulation of myostatin signaling.
    Kemaladewi DU; de Gorter DJ; Aartsma-Rus A; van Ommen GJ; ten Dijke P; 't Hoen PA; Hoogaars WM
    FASEB J; 2012 Apr; 26(4):1462-72. PubMed ID: 22202673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A.
    Lee SJ; Lehar A; Liu Y; Ly CH; Pham QM; Michaud M; Rydzik R; Youngstrom DW; Shen MM; Kaartinen V; Germain-Lee EL; Rando TA
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):30907-30917. PubMed ID: 33219121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibromodulin: a master regulator of myostatin controlling progression of satellite cells through a myogenic program.
    Lee EJ; Jan AT; Baig MH; Ashraf JM; Nahm SS; Kim YW; Park SY; Choi I
    FASEB J; 2016 Aug; 30(8):2708-19. PubMed ID: 27069062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells.
    Danila DC; Zhang X; Zhou Y; Haidar JN; Klibanski A
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4741-6. PubMed ID: 12364468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ActRIIB:ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders.
    Li J; Fredericks M; Cannell M; Wang K; Sako D; Maguire MC; Grenha R; Liharska K; Krishnan L; Bloom T; Belcheva EP; Martinez PA; Castonguay R; Keates S; Alexander MJ; Choi H; Grinberg AV; Pearsall RS; Oh P; Kumar R; Suragani RN
    J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural disease history of the D2
    van Putten M; Putker K; Overzier M; Adamzek WA; Pasteuning-Vuhman S; Plomp JJ; Aartsma-Rus A
    FASEB J; 2019 Jul; 33(7):8110-8124. PubMed ID: 30933664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activin B can signal through both ALK4 and ALK7 in gonadotrope cells.
    Bernard DJ; Lee KB; Santos MM
    Reprod Biol Endocrinol; 2006 Oct; 4():52. PubMed ID: 17040568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice.
    McCroskery S; Thomas M; Platt L; Hennebry A; Nishimura T; McLeay L; Sharma M; Kambadur R
    J Cell Sci; 2005 Aug; 118(Pt 15):3531-41. PubMed ID: 16079293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.
    Fakhfakh R; Michaud A; Tremblay JP
    Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplodeficiency of activin receptor-like kinase 4 alleviates myocardial infarction-induced cardiac fibrosis and preserves cardiac function.
    Chen YH; Wang Q; Li CY; Hou JW; Chen XM; Zhou Q; Chen J; Wang YP; Li YG
    J Mol Cell Cardiol; 2017 Apr; 105():1-11. PubMed ID: 28214509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.
    Tsuchida K
    Acta Myol; 2008 Jul; 27(1):14-8. PubMed ID: 19108572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of myostatin, myostatin receptors and follistatin in diabetic rats submitted to exercise.
    Dutra DB; Bueno PG; Silva RN; Nakahara NH; Selistre-Araújo HS; Nonaka KO; Leal AM
    Clin Exp Pharmacol Physiol; 2012 May; 39(5):417-22. PubMed ID: 22332899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
    Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
    FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx mice.
    Hulmi JJ; Oliveira BM; Silvennoinen M; Hoogaars WM; Pasternack A; Kainulainen H; Ritvos O
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E171-82. PubMed ID: 23695214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.
    Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Wang J; Fan Z; Liu N; Warsing LC; Grange RW; Ahn M; Balog-Alvarez CJ; Cotten SW; Willis MS; Brinkmeyer-Langford C; Zhu H; Palandra J; Morris CA; Styner MA; Wagner KR
    Skelet Muscle; 2016; 6():14. PubMed ID: 27047655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle.
    Hammers DW; Hart CC; Patsalos A; Matheny MK; Wright LA; Nagy L; Sweeney HL
    JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31830002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative auto-regulation of myostatin expression is mediated by Smad3 and microRNA-27.
    McFarlane C; Vajjala A; Arigela H; Lokireddy S; Ge X; Bonala S; Manickam R; Kambadur R; Sharma M
    PLoS One; 2014; 9(1):e87687. PubMed ID: 24498167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of PPARβ/δ adversely affects satellite cells and reduces postnatal myogenesis.
    Chandrashekar P; Manickam R; Ge X; Bonala S; McFarlane C; Sharma M; Wahli W; Kambadur R
    Am J Physiol Endocrinol Metab; 2015 Jul; 309(2):E122-31. PubMed ID: 25921579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.